NPR

Pricey New Cholesterol Drug's Effect On Heart Disease Is More Modest Than Hoped

The injectible drug Repatha is spectacularly good at lowering cholesterol. But the first big clinical trial of its ability to prevent heart attack and stroke finds smaller benefits.
Source: Dan Woodruff

Another cardiology meeting, another big prevention trial – and questions abound. People at risk for cardiovascular disease will be wondering about the implications for them. So are the doctors. New trials take some time to digest – and yet our news cycle wants quick, succinct answers. Sometimes it is not an easy call.

So here is what happened. For the past couple of years, experts in prevention have debated the merits of two new drugs, evolocumab and alirocumab (known as Repatha and Praluent), that were approved by the FDA in 2015 for the treatment of high cholesterol.

These drugs, which emerged from some very clever basic science, were distinctive in that they simulated a favorable genetic variation and

You’re reading a preview, subscribe to read more.

More from NPR

NPR4 min readWorld
China Launches A New Crew To Its Space Station, Advancing Toward Lunar Mission
Three astronauts will spend six months on China's space station. Some experts worry China's ambitious space program could pose a threat to U.S. space superiority and military effectiveness.
NPR5 min readFinance & Money Management
Housing Experts Say There Just Aren't Enough Homes In The U.S.
The United States is millions of homes short of demand, and lacks enough affordable housing units. And many Americans feel like housing costs are eating up too much of their take-home pay.
NPR4 min readInternational Relations
An American Hostage Is Seen Alive For The First Time Since Oct. 7 In A Hamas Video
Hersh Goldberg-Polin, who turned 24 last month while in captivity, has spent more than 200 days in captivity. His left arm was partially blown off by a grenade during the Hamas-led attack on Oct. 7.

Related Books & Audiobooks